| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73857 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73858 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73856 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-38342-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73858 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73856 | |||
![Western Blot: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Western-Blot-NBP2-45570-img0013.jpg "Western Blot: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2.")
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0012.jpg)
![Flow Cytometry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by RFC2 antibody.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Flow-Cytometry-NBP2-45570-img0001.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human breast tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0002.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0003.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0004.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0005.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0006.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human Ovary tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0007.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0008.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0009.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0010.jpg)
![Immunohistochemistry: RFC2 Antibody (2B2) [NBP2-45570] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/RFC2-Antibody-2B2-Immunohistochemistry-NBP2-45570-img0011.jpg)
![Western Blot: RFC2 Antibody [NBP1-89341] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NBP1-89341-img0006.jpg "Western Blot: RFC2 Antibody [NBP1-89341] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).")
![Immunocytochemistry/Immunofluorescence: RFC2 Antibody [NBP1-89341] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm.](http://images.novusbio.com/fullsize/RFC2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89341-img0007.jpg)
![Immunohistochemistry-Paraffin: RFC2 Antibody [NBP1-89341] - Staining of human vulva/anal skin shows strong nuclear positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/RFC2-Antibody-Immunohistochemistry-Paraffin-NBP1-89341-img0002.jpg)
![Western Blot: RFC2 Antibody [NBP1-89341] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG sp](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NBP1-89341-img0005.jpg)
![Immunohistochemistry: RFC2 Antibody [NBP1-89341] - RFC2 expression correlated with clinicopathological features in our LGG samples. The immunohistochemistry images showing the relative expression of RFC2 in LGG tissues and benign brain tumor tissues (Original magnification, x 400). Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/35210438/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/nbp1-89341_rabbit-polyclonal-rfc2-antibody-2552023151492.jpg)
![Immunohistochemistry: RFC2 Antibody [NBP1-89341] - Comparison of RFC2 expression between tumor & normal tissues (left, red represented tumor tissues while blue represented normal tissues) & corresponding immunohistochemistry images in normal tissues (middle) & tumor tissues (right). (A–F) The differential expression levels of RFC2 in glioblastoma (GBM) tissues (A), diffuse lower-grade gliomas (LGG) tissues (B), cervical cancer (CESC) tissues (C), colon adenocarcinoma (COAD) tissues (D), liver hepatocellular carcinoma (LIHC) tissues (E), lung squamous cell carcinoma (LUSC) tissues (F), & their corresponding normal tissues were evaluated based on GEPIA & HPA databases. (*P < 0.05). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/35210438), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-89341_rabbit-polyclonal-rfc2-antibody-3102024153567.jpg)
![Western Blot: RFC2 Antibody (4C11) [NBP2-03934] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RFC2.](http://images.novusbio.com/fullsize/RFC2-Antibody-4C11-Western-Blot-NBP2-03934-img0002.jpg "Western Blot: RFC2 Antibody (4C11) [NBP2-03934] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RFC2.")
![Immunohistochemistry-Paraffin: RFC2 Antibody (4C11) [NBP2-03934] Staining of paraffin-embedded Human tonsil using anti-RFC2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/RFC2-Antibody-4C11-Immunohistochemistry-Paraffin-NBP2-03934-img0005.jpg)
![Flow Cytometry: RFC2 Antibody (4C11) [NBP2-03934] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-RFC2 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/RFC2-Antibody-4C11-Flow-Cytometry-NBP2-03934-img0001.jpg)
![Immunohistochemistry-Paraffin: RFC2 Antibody (4C11) [NBP2-03934] - Staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-RFC2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/RFC2-Antibody-4C11-Immunohistochemistry-Paraffin-NBP2-03934-img0003.jpg)
![Immunohistochemistry-Paraffin: RFC2 Antibody (4C11) [NBP2-03934] - Staining of paraffin-embedded Human pancreas tissue using anti-RFC2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/RFC2-Antibody-4C11-Immunohistochemistry-Paraffin-NBP2-03934-img0004.jpg)
![Western Blot: RFC2 Antibody [NBP1-32253] - Various whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with RFC2 antibody diluted by 1:1000.](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NBP1-32253-img0003.jpg "Western Blot: RFC2 Antibody [NBP1-32253] - Various whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with RFC2 antibody diluted by 1:1000.")
![Immunocytochemistry/Immunofluorescence: RFC2 Antibody [NBP1-32253] - Paraformaldehyde-fixed HeLa, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/RFC2-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32253-img0002.jpg)
![Western Blot: RFC2 Antibody [NBP1-32253] - A: A431 B: H1299 C: Hela 10% SDS PAGE; antibody diluted at 1:1000](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NBP1-32253-img0001.jpg)
![Western Blot: RFC2 Antibody (11C6) [NBP2-45569] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2.](http://images.novusbio.com/fullsize/RFC2-Antibody-11C6-Western-Blot-NBP2-45569-img0002.jpg "Western Blot: RFC2 Antibody (11C6) [NBP2-45569] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RFC2.")
![Flow Cytometry: RFC2 Antibody (11C6) [NBP2-45569] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by RFC2 antibody.](http://images.novusbio.com/fullsize/RFC2-Antibody-11C6-Flow-Cytometry-NBP2-45569-img0001.jpg)
![Western Blot: RFC2 Antibody [NB100-231] - Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-RFC2 antibody used for WB at 0.2 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NB100-231-img0003.jpg "<b>Biological Strategies Validation. </b>Western Blot: RFC2 Antibody [NB100-231] - Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-RFC2 antibody used for WB at 0.2 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.")
![<b>Biological Strategies Validation. </b>Western Blot: RFC2 Antibody [NB100-231] - Whole cell extract (50 ug) from MCF7 and 293T cells (A) or nuclear extract (50 ug) from HeLa cells (B). Antibody used at 0.5 ug/ml (A) and 1 ug/ml (B).](http://images.novusbio.com/fullsize/RFC2-Antibody-Western-Blot-NB100-231-img0002.jpg)
![SDS-Page: Recombinant Human RFC2 Protein [H00005982-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.](http://images.novusbio.com/fullsize/qc_test-H00005982-P01-1.jpg "SDS-Page: Recombinant Human RFC2 Protein [H00005982-P01] - 12.5% SDS-PAGE Stained with Coomassie Blue.")
![Western Blot: RFC2 Antibody [NBP3-38342] - Western blot analysis of various lysates using RFC2 Rabbit pAb at 1:1000 dilution.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 5s.](http://images.novusbio.com/fullsize/nbp3-38342_rabbit-rfc2-pab-101220241224182.jpg "Western Blot: RFC2 Antibody [NBP3-38342] - Western blot analysis of various lysates using RFC2 Rabbit pAb at 1:1000 dilution.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 5s.")
![Western Blot: RFC2 Overexpression Lysate (Adult Normal) [NBL1-15292] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for RFC2.](http://images.novusbio.com/fullsize/RFC2-Overexpression-Lysate-Adult-Normal-Western-Blot-NBL1-15292-img0002.jpg "Western Blot: RFC2 Overexpression Lysate (Adult Normal) [NBL1-15292] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for RFC2.")